Results: 2

1.
Fig 2.

Fig 2. From: Finasteride to Prevent Prostate Cancer: Should All Men or Only a High-Risk Subgroup Be Treated?.

Absolute risk reduction of for-cause–detected cancers between placebo and finasteride groups predicted by prostate-specific antigen (PSA) at baseline.

Andrew J. Vickers, et al. J Clin Oncol. 2010 March 1;28(7):1112-1116.
2.
Fig 1.

Fig 1. From: Finasteride to Prevent Prostate Cancer: Should All Men or Only a High-Risk Subgroup Be Treated?.

Absolute risk reduction of all cancers between placebo and finasteride groups predicted by prostate-specific antigen (PSA) at baseline.

Andrew J. Vickers, et al. J Clin Oncol. 2010 March 1;28(7):1112-1116.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk